U
QSAM Biosciences, Inc. A408WA
Recommendation
--
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
--
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
--

12/31/2023 09/30/2023 06/30/2023 03/31/2023 12/31/2022
Net Income 58.44% 5.95% 17.86% -28.16% 4.69%
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -- -- -100.00% 298.90% 0.00%
Total Other Non-Cash Items -86.57% 10.92% -55.44% 71.45% 0.17%
Change in Net Operating Assets -332.84% 372.74% -67.83% 144.37% -260.47%
Cash from Operations -161.84% 44.92% -82.61% 61.75% -153.02%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -80.00% 45.90% -67.87% 123.37% -48.38%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 320.00% 45.90% -67.87% 123.37% -48.38%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 1,551.67% 112.32% -173.74% 192.89% -243.43%
Weiss Ratings